A page in the reference notebook
Dulaglutide
Also listed as: Trulicity
Keep the record, its references, and your reading question together.
- Product status
- Approved product
- Evidence label
- Randomized evidence
- Body topics
- Metabolism
Status as of
Reference fields
Read the fields together.
- Mechanism
- GLP-1 receptor agonist fusion protein.
- Evidence
- Randomized studies.
- Limitations
- No weight-management indication.
- Safety
- Not recommended for severe gastroparesis.
- Route and product context
- Subcutaneous injection.
- Approval scope
- Trulicity: specified type 2 diabetes populations.
A little room to think
One clearer reading question.
A conclusion becomes easier to evaluate when its author explains what would lead them to reconsider it. Look for a reasoned standard, rather than a promise to change their mind whenever a new result appears. Different objections may carry different weight. One could question the measurement; another could challenge the step from measurement to conclusion. Identify which step matters most to the argument, then ask what would strengthen or weaken it. The aim is a conclusion that can be revised for a clear reason, with the reasoning visible to the reader.
Questions to keep nearby
- Which step in this argument carries the most weight for its conclusion?
- What finding would give a clear reason to reconsider that particular step?
- Would the same standard apply to evidence that supports and challenges the conclusion?
Follow the record
Source list
- TRULICITY
NLM · Checked